Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Vascular Surgery

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 93 articles: HTML format Text format

Single Articles

November 2011
1. NAMMAS W
   Delayed arterial healing 5 years after implantation of sirolimus-eluting stents: no smoke without fire.
   Am Heart J. 2011;162:e29.
   PubMed     Text format     Related articles   
   
   
   
   
2. JONES WS , Patel MR, Holleran SA, Harrison JK, et al
   Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.
   Am Heart J. 2011;162:932-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GUTIERREZ-CHICO JL , Juni P, Garcia-Garcia HM, Regar E, et al
   Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.
   Am Heart J. 2011;162:922-31.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. STOLKER JM , Cohen DJ, Lindsey JB, Kennedy KF, et al
   Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.
   Am Heart J. 2011;162:914-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PUYMIRAT E , Mangiacapra F, Peace A, Sharif F, et al
   Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting.
   Am Heart J. 2011;162:907-13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KALAVROUZIOTIS D , Buth KJ, Cox JL, Baskett RJ, et al
   Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and beta-blockers after coronary artery bypass graft surgery.
   Am Heart J. 2011;162:836-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MAURI L , Normand SL, Pencina M, Cutlip DE, et al
   Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site.
   Am Heart J. 2011;162:826-31.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
8. SCHWARZ N , Schoenburg M, Mollmann H, Kastaun S, et al
   Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting.
   Am Heart J. 2011;162:756-63.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KELLY DJ , Gershlick T, Witzenbichler B, Guagliumi G, et al
   Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial.
   Am Heart J. 2011;162:663-70.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. PARIKH PB , Gruberg L, Jeremias A, Chen JJ, et al
    Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention.
    Am Heart J. 2011;162:512-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KESSLER DP , Kroch E, Hlatky MA
    The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction.
    Am Heart J. 2011;162:494-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
12. VARENHORST C , Koul S, Erlinge D, Lagerqvist B, et al
    Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study.
    Am Heart J. 2011;162:363-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
13. CHUNG SC , Hlatky MA, Stone RA, Rana JS, et al
    Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).
    Am Heart J. 2011;162:184-192.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. WU J , Pride YB, Frederick PD, Gibson CM, et al
    Association of initial Thrombolysis in Myocardial Infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A National Registry of Myocardial Infarction-5
    Am Heart J. 2011;162:178-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CRISTEA E , Stone GW, Mehran R, Kirtane AJ, et al
    Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: Implications for appropriate stent sizing.
    Am Heart J. 2011;162:173-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. BANKA P , Sleeper LA, Atz AM, Cowley CG, et al
    Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study.
    Am Heart J. 2011;162:125-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. FRENCH JK , Armstrong PW, Cohen E, Kleiman NS, et al
    Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    Am Heart J. 2011;162:89-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. PATEL MR , Thiele H, Smalling RW, Chandra P, et al
    A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduc
    Am Heart J. 2011;162:47-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. BOOHER AM , Eagle KA
    Diagnosis and management issues in thoracic aortic aneurysm.
    Am Heart J. 2011;162:38-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. RAPOSEIRAS-ROUBIN S , Pardal CB, Ocaranza R, Cid B, et al
    Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Am Heart J. 2011;162:e7.
    PubMed     Text format     Related articles   
    
    
    
    
21. LIN GM , Li YH, Chu KM, Han CL, et al
    Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry.
    Am Heart J. 2011;162:e17.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
22. PRADA-DELGADO O , Estevez-Loureiro R, Calvino-Santos R, Barge-Caballero E, et al
    Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Am Heart J. 2011;161:1207-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. YAMAMOTO M , Takano M, Murakami D, Inami T, et al
    The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
    Am Heart J. 2011;161:1200-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SZEKELY A , Nussmeier NA, Miao Y, Huang K, et al
    A multinational study of the influence of health-related quality of life on in-hospital outcome after coronary artery bypass graft surgery.
    Am Heart J. 2011;161:1179-1185.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SURIE S , Bouma BJ, Bruin-Bon RA, Hardziyenka M, et al
    Time course of restoration of systolic and diastolic right ventricular function after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Am Heart J. 2011;161:1046-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
26. BURKE MA , Lee R, Fintel DJ
    Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.
    Am Heart J. 2011;161:832-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. MAURI L , Leon MB, Yeung AC, Negoita M, et al
    Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial).
    Am Heart J. 2011;161:807-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. REFIKER M
    Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting surgery.
    Am Heart J. 2011;161:e25.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
29. MEHTA RH , Starr AZ, Lopes RD, Piccini JP, et al
    Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.
    Am Heart J. 2011;161:782-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. MAGRO M , Nauta S, Simsek C, Onuma Y, et al
    Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.
    Am Heart J. 2011;161:771-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KO DT , Atzema CL, Donovan LR, Graham MM, et al
    Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: A population-based study.
    Am Heart J. 2011;161:764-770.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. NEWELL MC , Henry JT, Henry TD, Duval S, et al
    Impact of age on treatment and outcomes in ST-elevation myocardial infarction.
    Am Heart J. 2011;161:664-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. MONTALESCOT G , Bolognese L, Dudek D, Goldstein P, et al
    A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: Design and rationale for the ACCOAST study.
    Am Heart J. 2011;161:650-656.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
34. KUMBHANI DJ , Bavry AA, Harvey JE, de Souza R, et al
    Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.
    Am Heart J. 2011;161:622-630.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. UDELSON JE , Pearte CA, Kimmelstiel CD, Kruk M, et al
    The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
    Am Heart J. 2011;161:611-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. GURBEL PA , Shuldiner AR, Bliden KP, Ryan K, et al
    The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy.
    Am Heart J. 2011;161:598-604.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. ARAGAM KG , Moscucci M, Smith DE, Riba AL, et al
    Trends and disparities in referral to cardiac rehabilitation after percutaneous coronary intervention.
    Am Heart J. 2011;161:544-551.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. DE BOER SP , Barnes EH, Westerhout CM, Simes RJ, et al
    High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration.
    Am Heart J. 2011;161:500-507.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. GIBSON CM , Maehara A, Lansky AJ, Wohrle J, et al
    Rationale and design of the INFUSE-AMI study: A 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST
    Am Heart J. 2011;161:478-486.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. CAPODANNO D , Tamburino C
    Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: Use, pitfalls, and new directions.
    Am Heart J. 2011;161:462-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. WHITE HD
    Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
    Am Heart J. 2011;161:450-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
42. HAKIM DA , Dangas GD, Caixeta A, Nikolsky E, et al
    Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORI
    Am Heart J. 2011;161:391-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LONGMUIR PE , Russell JL, Corey M, Faulkner G, et al
    Factors associated with the physical activity level of children who have the Fontan procedure.
    Am Heart J. 2011;161:411-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CRUDEN NL , Morch K, Wong DR, Klinke WP, et al
    Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting.
    Am Heart J. 2011;161:404-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. HOLPER EM , Abbott JD, Mulukutla S, Vlachos H, et al
    Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.
    Am Heart J. 2011;161:397-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. KO YG , Suh JW, Kim BH, Lee CJ, et al
    Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention.
    Am Heart J. 2011;161:383-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. CHOI CU , Rha SW, Oh DJ, Poddar KL, et al
    Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry.
    Am Heart J. 2011;161:373-382.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. WESTERHOUT CM , Bonnefoy E, Welsh RC, Steg PG, et al
    The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST.
    Am Heart J. 2011;161:283-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. JOLLY SS , Niemela K, Xavier D, Widimsky P, et al
    Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes.
    Am Heart J. 2011;161:254-260.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. TARANTINI G , Van de Werf F, Bilato C, Gersh B, et al
    Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait? The risk-time relationship and the need to quantify the impact of delay.
    Am Heart J. 2011;161:247-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
51. SCIAHBASI A , Romagnoli E, Burzotta F, Trani C, et al
    Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study.
    Am Heart J. 2011;161:172-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. JACKSON EA , Moscucci M, Smith DE, Share D, et al
    The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (B
    Am Heart J. 2011;161:106-112.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. KAUL P , Armstrong PW, Sookram S, Leung BK, et al
    Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction.
    Am Heart J. 2011;161:91-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. WANG TY , Peterson ED, Ou FS, Nallamothu BK, et al
    Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: A report from the National Cardiovascular Data Registry.
    Am Heart J. 2011;161:76-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. COLLET JP , Cayla G, Cuisset T, Elhadad S, et al
    Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopido
    Am Heart J. 2011;161:5-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
56. ZIMARINO M , Ruggieri B, De Caterina R
    Patient management and care after primary percutaneous coronary intervention: reinforcing a continuum of care after primary percutaneous coronary intervention.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. ESPOSITO G , Dellegrottaglie S, Chiariello M
    The extent of irreversible myocardial damage and the potential for left ventricular repair after primary percutaneous coronary intervention.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. VALGIMIGLI M , Minarelli M
    Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: Balancing safety and efficacy.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. BIONDI-ZOCCAI G , Lotrionte M, Sheiban I
    Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. DE LUCA L , Tomai F, Verdoia M, De Luca G, et al
    Evaluation and management of special subgroups after primary percutaneous coronary intervention.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. SAIA F , Grigioni F, Marzocchi A, Branzi A, et al
    Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. PARODI G , Antoniucci D
    Left ventricular remodeling after primary percutaneous coronary intervention.
    Am Heart J. 2010;160.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. SUN JC , Teoh KH, Lamy A, Sheth T, et al
    Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
    Am Heart J. 2010;160:1178-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MARENZI G , De Metrio M, Rubino M, Lauri G, et al
    Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention.
    Am Heart J. 2010;160:1170-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. RAEDLE-HURST TM , Koenigstein K, Gruenhage F, Raedle J, et al
    Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
    Am Heart J. 2010;160:1105-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. COHEN MS , Zak V, Atz AM, Printz BF, et al
    Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome.
    Am Heart J. 2010;160:1092-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. FROBERT O , Lagerqvist B, Gudnason T, Thuesen L, et al
    Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design
    Am Heart J. 2010;160:1042-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. MAURI L , Kereiakes DJ, Normand SL, Wiviott SD, et al
    Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coro
    Am Heart J. 2010;160:1035-1041.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. PORTO I , Hamilton-Craig C, Brancati M, Burzotta F, et al
    Angiographic assessment of microvascular perfusion-Myocardial blush in clinical practice.
    Am Heart J. 2010;160:1015-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
70. DUDEK D , Mielecki W, Burzotta F, Gasior M, et al
    Thrombus aspiration followed by direct stenting: A novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial).
    Am Heart J. 2010;160:966-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. HASSAN A , Newman A, Ko DT, Rinfret S, et al
    Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005.
    Am Heart J. 2010;160:958-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. KIM MS , Wang TY, Ou FS, Klein AJ, et al
    Association of prior coronary artery bypass graft surgery with quality of care of patients with non-ST-segment elevation myocardial infarction: A report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes
    Am Heart J. 2010;160:951-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. WONG CK , de la Barra SL, Herbison P
    Does ST resolution achieved via different reperfusion strategies (fibrinolysis vs percutaneous coronary intervention) have different prognostic meaning in ST-elevation myocardial infarction? A systematic review.
    Am Heart J. 2010;160:842-848.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. ABU-ASSI E , Ferreira-Gonzalez I, Ribera A, Marsal JR, et al
    "Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?".
    Am Heart J. 2010;160:826-834.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. VALGIMIGLI M , Campo G, Percoco G, Monti M, et al
    Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatm
    Am Heart J. 2010;160:804-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. LU C , Chen YC
    Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention (Am Heart J 2010;159:876-81).
    Am Heart J. 2010;160:e35.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
77. NISHINO M , Hoshida S, Taniike M, Kato H, et al
    Vulnerable disease may induce neointimal coverage after sirolimus-eluting stent implantation.
    Am Heart J. 2010;160:564-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. ARADI D , Komocsi A, Vorobcsuk A, Rideg O, et al
    Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis.
    Am Heart J. 2010;160:543-551.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. ROMAGNOLI E , De Servi S, Tamburino C, Colombo A, et al
    Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: Results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS).
    Am Heart J. 2010;160:535-542.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. TIROCH KA , Sibbing D, Koch W, Roosen-Runge T, et al
    Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events.
    Am Heart J. 2010;160:506-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. TRAVERSE JH , McKenna DH, Harvey K, Jorgenso BC, et al
    Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.
    Am Heart J. 2010;160:428-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. ELBAROUNI B , Elmanfud O, Yan RT, Fox KA, et al
    Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
    Am Heart J. 2010;160:420-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. DE MULDER M , Cornel JH, van der Ploeg T, Boersma E, et al
    Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy.
    Am Heart J. 2010;160:412-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. VAN KUIJK JP , Voute MT, Flu WJ, Schouten O, et al
    The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation App
    Am Heart J. 2010;160:387-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. ANUSIONWU OF , Shah N
    Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.
    Am Heart J. 2010;160:e25.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
86. SCHULZ S , Sibbing D, Braun S, Morath T, et al
    Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.
    Am Heart J. 2010;160:355-361.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. AASA M , Henriksson M, Dellborg M, Grip L, et al
    Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
    Am Heart J. 2010;160:322-328.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. LINDAHL B , Venge P, James S
    The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes.
    Am Heart J. 2010;160:224-229.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. NAMMAS W , Hossam K
    Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.
    Am Heart J. 2010;160:e13.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
90. LARSON DM , Duval S, Sharkey SS, Solie C, et al
    Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary Intervention.
    Am Heart J. 2010;160:202-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. BERRY C , Noble S, Ibrahim R, Gregoire J, et al
    Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease.
    Am Heart J. 2010;160:188-194.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MISTRY N , Bohmer E, Hoffmann P, Muller C, et al
    Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy.
    Am Heart J. 2010;160:73-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. LEONARDI S , Rao SV, Harrington RA, Bhatt DL, et al
    Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutane
    Am Heart J. 2010;160:65-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: